IRON
Price
$62.31
Change
+$0.15 (+0.24%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
2.16B
43 days until earnings call
VRNA
Price
$106.38
Change
+$0.13 (+0.12%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
9.19B
48 days until earnings call
Interact to see
Advertisement

IRON vs VRNA

Header iconIRON vs VRNA Comparison
Open Charts IRON vs VRNABanner chart's image
Disc Medicine
Price$62.31
Change+$0.15 (+0.24%)
Volume$2.69K
Capitalization2.16B
Verona Pharma
Price$106.38
Change+$0.13 (+0.12%)
Volume$4.71K
Capitalization9.19B
IRON vs VRNA Comparison Chart in %
Loading...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRON vs. VRNA commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRON is a Buy and VRNA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (IRON: $62.16 vs. VRNA: $106.25)
Brand notoriety: IRON and VRNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRON: 96% vs. VRNA: 76%
Market capitalization -- IRON: $2.16B vs. VRNA: $9.19B
IRON [@Biotechnology] is valued at $2.16B. VRNA’s [@Biotechnology] market capitalization is $9.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRON’s FA Score shows that 0 FA rating(s) are green whileVRNA’s FA Score has 1 green FA rating(s).

  • IRON’s FA Score: 0 green, 5 red.
  • VRNA’s FA Score: 1 green, 4 red.
According to our system of comparison, both IRON and VRNA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRON’s TA Score shows that 5 TA indicator(s) are bullish while VRNA’s TA Score has 3 bullish TA indicator(s).

  • IRON’s TA Score: 5 bullish, 2 bearish.
  • VRNA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IRON is a better buy in the short-term than VRNA.

Price Growth

IRON (@Biotechnology) experienced а +3.02% price change this week, while VRNA (@Biotechnology) price change was -0.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

IRON is expected to report earnings on Nov 06, 2025.

VRNA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRNA($9.19B) has a higher market cap than IRON($2.16B). VRNA YTD gains are higher at: 128.790 vs. IRON (-1.956). VRNA has higher annual earnings (EBITDA): -34.62M vs. IRON (-142.42M). IRON has more cash in the bank: 650M vs. VRNA (438M). IRON has less debt than VRNA: IRON (30.9M) vs VRNA (244M). VRNA has higher revenues than IRON: VRNA (222M) vs IRON (0).
IRONVRNAIRON / VRNA
Capitalization2.16B9.19B24%
EBITDA-142.42M-34.62M411%
Gain YTD-1.956128.790-2%
P/E RatioN/AN/A-
Revenue0222M-
Total Cash650M438M148%
Total Debt30.9M244M13%
FUNDAMENTALS RATINGS
VRNA: Fundamental Ratings
VRNA
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
2
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IRONVRNA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 13 days ago
79%
Declines
ODDS (%)
Bearish Trend 27 days ago
81%
Bearish Trend 6 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDVVX25.750.07
+0.27%
JHancock Disciplined Value R5
ALVIX11.130.03
+0.25%
American Century Focused Lg Cap Val Inv
GSSIX43.84-0.04
-0.09%
Goldman Sachs Small Cap Value Inst
SCIZX7.66-0.01
-0.13%
Virtus SGA International Growth R6
BFINX18.04-0.07
-0.41%
Baron FinTech Retail

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+1.08%
SYRE - IRON
53%
Loosely correlated
+4.77%
CGON - IRON
51%
Loosely correlated
-0.92%
XNCR - IRON
50%
Loosely correlated
-0.67%
CRNX - IRON
50%
Loosely correlated
+6.35%
KMSTF - IRON
49%
Loosely correlated
N/A
More

VRNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRNA has been loosely correlated with RYTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VRNA jumps, then RYTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRNA
1D Price
Change %
VRNA100%
N/A
RYTM - VRNA
47%
Loosely correlated
-0.30%
IRON - VRNA
42%
Loosely correlated
+1.08%
ZYME - VRNA
42%
Loosely correlated
-1.03%
BBIO - VRNA
39%
Loosely correlated
-0.08%
OCUL - VRNA
36%
Loosely correlated
+0.41%
More